The Journal of the American Dental Association
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Dent Assoc, Vol 139, No 2, 178-183.
© 2008 American Dental Association

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCoy, L. C.
Right arrow Articles by Jones, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCoy, L. C.
Right arrow Articles by Jones, J. A.
Related Collections
Right arrow Periodontics

RESEARCH

JADA Continuing Education

Adverse events associated with chlorhexidine use

Results from the Department of Veterans Affairs Dental Diabetes Study



Linda C. McCoy, RDH, MS, Carolyn J. Wehler, RDH, MPH, Sharron E. Rich, MPH, Raul I. Garcia, DMD, MMedSc, Donald R. Miller, ScD and Judith A. Jones, DDS, MPH, DScD

Background. The authors report adverse events (AEs) related to the use of chlorhexidine gluconate mouthrinse in a clinical trial of the efficacy of periodontal treatment in older adults with diabetes.

Methods. Participants were U.S. veterans with uncontrolled diabetes (hemoglobin A1c value ≥8.5 percent) and periodontal disease. Treatment included periodontal scaling, 0.12 percent chlorhexidine lavage during ultrasonic scaling and use of chlorhexidine mouthrinse at home.

Results. Forty-four (31 percent) of 140 subjects reported having AEs. Most common were taste changes and tooth staining, sore mouth and/or throat, tongue irritation and wheezing/shortness of breath; the latter was reported more commonly before chlorhexidine use than after. Only body mass index greater than 30 was significantly related to AEs.

Conclusions. AEs are common among subjects using chlorhexidine mouthrinse. Most AEs (taste change and staining) were resolved easily by subjects’ discontinuing mouthrinse use and receiving dental prophylaxis. No serious AEs were reported.

Clinical Implications. Clinicians should advise patients using chlorhexidine mouthrinse of possible side effects. If necessary, patients should discontinue mouthrinse use and obtain medical care. Careful monitoring of AEs in patients using chlorhexidine is warranted.

Key Words: Chlorhexidine gluconate; mouthrinse; periodontal disease; diabetes

Abbreviations: AE: Adverse event. • BMI: Body mass index. • CI: Comorbidity index. • DCI: Diabetes Complications Index. • HbA1c: Hemoglobin A1c. • VA: Veterans Affairs.




This article has been cited by other articles:


Home page
J Dent EducHome page
S. Lohiya
Postmeal Toothwash
J Dent Educ., June 1, 2009; 73(6): 655 - 655.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright©1995-2008 American Dental Association (ADA).
Reproduction or republication strictly prohibited without prior written permission of ADA.